HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A cysteine-reactive alkyl hydroquinone modifies topoisomerase IIα, enhances DNA breakage, and induces apoptosis in cancer cells.

Abstract
We previously reported that the anticancer activity of a botanical compound 10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone [HQ17(3)] was attributed to topoisomerase (Topo) IIα poisoning and the induction of oxidative damage. HQ17(3) irreversibly inhibits Topo IIα activity in vitro and is more cytotoxic in leukemia HL-60 cells than in Topo IIα-deficient variant HL-60/MX2 cells, which suggests that Topo IIα is a cellular target of HQ17(3). This study further characterizes the molecular mechanisms of the anticancer activity of HQ17(3). Proteomic analyses indicated that HQ17(3) reacted with Cys-427, Cys-733, and Cys-997 of recombinant Topo IIα in vitro, whereas it reacted with Cys-427 of cellular Topo IIα in Huh7 hepatoma cells. The modification of HQ17(3) inhibited Topo IIα catalytic activity, increased the Topo IIα-DNA cleavage complex, and caused the accumulation of DNA breakage. In Huh7 cells, HQ17(3) treatment caused prompt inhibition of DNA synthesis and consequently induced the expression of DNA damage-related genes DDIT3, GADD45A, and GADD45G. Topo IIα inhibition, apoptosis, and oxidative stress were found to account for cytotoxicity caused by HQ17(3). Pretreatment of Huh7 cells with N-acetylcysteine (NAC) partially attenuated mitochondrial membrane damage, DNA breakage, and caspase activation. However, NAC pretreatment did not diminish HQ17(3)-induced cell death. These results suggest that the anticancer activity of HQ17(3) is attributed significantly to Topo IIα poisoning. The structural feature of HQ17(3) can be used as a model for the design of Topo IIα inhibitors and anticancer drugs.
AuthorsTing-Yu Lin, Cheng-Po Huang, Lo-Chun Au, Ya-Wen Chang, Chung-Yi Hu, Shwu-Bin Lin
JournalChemical research in toxicology (Chem Res Toxicol) Vol. 25 Issue 11 Pg. 2340-51 (Nov 19 2012) ISSN: 1520-5010 [Electronic] United States
PMID23088786 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 10'(Z),13'(E),15'(E)-heptadecatrienylhydroquinone
  • Antigens, Neoplasm
  • Antineoplastic Agents
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Hydroquinones
  • DNA Topoisomerases, Type II
  • Cysteine
Topics
  • Antigens, Neoplasm (metabolism)
  • Antineoplastic Agents (chemistry, isolation & purification, pharmacology)
  • Apoptosis (drug effects)
  • Cell Survival (drug effects)
  • Cysteine (chemistry)
  • DNA Breaks (drug effects)
  • DNA Breaks, Double-Stranded (drug effects)
  • DNA Topoisomerases, Type II (metabolism)
  • DNA-Binding Proteins (antagonists & inhibitors, metabolism)
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Enzyme Inhibitors (chemistry, isolation & purification, pharmacology)
  • Flow Cytometry
  • Humans
  • Hydroquinones (chemistry, isolation & purification, pharmacology)
  • Structure-Activity Relationship
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: